Skip to main content
. 2023 Nov 10;9(11):e22111. doi: 10.1016/j.heliyon.2023.e22111

Table- 3.

P. aeruginosa gene expression in exposure to bile.

Gene symbol Function/presence Regulation/Expression in response to bile Technique Bile/bile salt Concentration Strain Ref.
mqoB Glyoxylate shunt pathway Increase Real-time PCR Bile 0.30 % PAO1 [50]
glcB Glyoxylate shunt pathway Increase Real-time PCR Bile 0.30 % PAO1 [50]
acnA The early stage of the TCA cycle Increase Real-time PCR Bile 0.30 % PAO1 [50]
idh The early stage of the TCA cycle Increase Real-time PCR Bile 0.30 % PAO1 [50]
PA0853-54 The late stages of the TCA cycle Decrease Real-time PCR Bile 0.30 % PAO1 [50]
aspA The late stages of the TCA cycle Decrease Real-time PCR Bile 0.30 % PAO1 [50]
lpdV glucose metabolism/glycolysis Decrease Real-time PCR Bile 0.30 % PAO1 [50]
gapA Glucose metabolism/glycolysis Decrease Real-time PCR Bile 0.30 % PAO1 [50]
glk Glucose metabolism/glycolysis Decrease Real-time PCR Bile 0.30 % PAO1 [50]
aceEF Glucose metabolism/glycolysis Decrease Real-time PCR Bile 0.30 % PAO1 [50]
pfm Proton motive force Decrease Real-time PCR Bile 0.30 % PAO1 [50]
pqsA Biofilm formation and virulence Increase Real-time PCR Bile 0.30 % PAO1 [50]
pqsA-E QS/biofilm formation and virulence Increase Promoter fusion and thin-layer chromatography Bile 0.30 % PA14, PAO1 and clinical isolates CF242 [27]
rhlI Acyl-homoserine-lactone synthase Increase Promoter fusion and thin-layer chromatography Bile 0.30 % PA14, PAO1 and clinical isolates CF242 [27]
lasI Acyl-homoserine-lactone synthase Increase Promoter fusion and thin-layer chromatography Bile 0.30 % PA14, PAO1 and clinical isolates CF242 [27]
psl Biofilm formation and virulence Increase Congo red binding assay Bile 0.30 % PAO1 [50]
psrA
Transcriptional regulator associated with biofilm formation
Increase Real-time PCR Bile 0.30 % PAO1 [50]
ppyR Transcriptional regulator associated with iron-scavenging and exopolysaccharide production Increase Real-time PCR Bile 0.30 % PAO1 [50]
ohrR Transcriptional regulator associated with oxidative stress response Increase Real-time PCR Bile 0.30 % PAO1 [50]
mexR Transcriptional regulator associated with secretion and antibiotic tolerance Increase Real-time PCR Bile 0.30 % PAO1 [50]
T3SS Type III secretion systems (associated with acute infection) Decrease Real-time PCR Bile 0.30 % PAO1 [50]
T3SS effector exoU Promoter activity of the T3SS effector exoU 8.9- fold decrease Real-time PCR Bile 0.30 % PA14, PAO1 and clinical isolates CF242 [27]
T6SS Type vI secretion systems Decrease Real-time PCR Bile 0.30 % PA14, PAO1 and clinical isolates CF242 [27]
hcnABC Hydrogen cyanide Decrease Real-time PCR Bile 0.30 % PAO1 [50]
amiR Amidase Decrease Real-time PCR Bile 0.30 % PAO1 [50]
phzA-E Phenazine Decrease Real-time PCR Bile 0.30 % PAO1 [50]
gnyR Transcriptional regulator associated with isoprenoid degrading Decrease Real-time PCR Bile 0.30 % UCBPP-PA14, PA14_38430 [50]
sfa2 Transcriptional regulator associated with T6SS HSI-II expression Decrease Real-time PCR Bile 0.30 % PAO1 [50]
mexAB-OprM Efflux pump/Antibiotic tolerance Increase Real-time PCR Bile 0.30 % PAO1 [50]
SiaA-D Transition to a sessile lifestyle through cyclic-di-GMP synthesis Upregulated Real-time PCR Bile 0.30 % PAO1 [50]
phzS PYO biosynthetic genes Increase qRT-PCR Bile 0.30 % PA14 [31]
phzH PYO biosynthetic genes No significant response qRT-PCR Bile 0.30 % PA14 [31]
phzM PYO biosynthetic genes No significant response qRT-PCR Bile 0.30 % PA14 [31]
gdbR Transcriptional regulator associated with choline Decrease Real-time PCR Bile 0.30 % PAO1 [50]